Probiotic lactobacilli attenuate oxysterols-induced alteration of intestinal epithelial cell monolayer permeability: Focus on tight junction modulation

Food Chem Toxicol. 2023 Feb:172:113558. doi: 10.1016/j.fct.2022.113558. Epub 2022 Dec 15.

Abstract

Oxidative stress and inflammation lead by dietary oxidised lipids, as oxysterols, have been linked to the loss of intestinal barrier integrity, a crucial event in the initiation and progression of intestinal disorders. In the last decade, probiotic lactobacilli have emerged as an interesting tool to improve intestinal health, thanks to their antioxidant and anti-inflammatory properties. The aim of the present study was to evaluate the ability of two commercial probiotic strains of lactobacilli (Lactiplantibacillus plantarum 299v® (DMS 9843) and Lacticaseibacillus casei DG® (CNCMI-1572)), both as live bacteria and intracellular content, to attenuate the oxysterols-induced alteration of intestinal epithelial Caco-2 cell monolayer permeability. Our investigation was focused on the modulation of tight junctions (TJs) proteins, occludin, ZO-1 and JAM-A, in relation to redox-sensitive MAPK p38 activation. Obtained results provided evidence on the ability of the two probiotics to counteract the alteration of monolayer permeability and loss of TJs proteins, at least in part, through the modulation of p38 pathway. The protective action was exerted by live bacteria, whose adhesion to Caco-2 cells was not altered by oxysterols, and bacterial intracellular components equally able to interact with the signaling pathway.

Keywords: Intestinal cells; Lactobacilli; MAP kinases; Oxysterols; Probiotics; Tight junctions.

MeSH terms

  • Caco-2 Cells
  • Epithelial Cells / metabolism
  • Humans
  • Intestinal Mucosa / metabolism
  • Lactobacillus
  • Oxysterols* / metabolism
  • Permeability
  • Probiotics* / pharmacology
  • Tight Junctions / metabolism

Substances

  • Oxysterols